Altimmune (ALT) EBT Margin (2016 - 2025)
Historic EBT Margin for Altimmune (ALT) over the last 17 years, with Q3 2025 value amounting to 380280.0%.
- Altimmune's EBT Margin rose 766200000.0% to 380280.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 423570.0%, marking a year-over-year decrease of 2244930800.0%. This contributed to the annual value of 475535.0% for FY2024, which is 4547727900.0% down from last year.
- Per Altimmune's latest filing, its EBT Margin stood at 380280.0% for Q3 2025, which was up 766200000.0% from 442920.0% recorded in Q2 2025.
- In the past 5 years, Altimmune's EBT Margin ranged from a high of 728.99% in Q4 2021 and a low of 1185650.0% during Q3 2022
- For the 5-year period, Altimmune's EBT Margin averaged around 274307.24%, with its median value being 251650.0% (2022).
- Its EBT Margin has fluctuated over the past 5 years, first tumbled by 2000000000bps in 2022, then soared by 2000000000bps in 2023.
- Over the past 5 years, Altimmune's EBT Margin (Quarter) stood at 728.99% in 2021, then crashed by -11328bps to 83307.69% in 2022, then decreased by -3bps to 85516.22% in 2023, then crashed by -445bps to 465960.0% in 2024, then increased by 18bps to 380280.0% in 2025.
- Its last three reported values are 380280.0% in Q3 2025, 442920.0% for Q2 2025, and 405120.0% during Q1 2025.